Guardant Health (GH) closed the last trading session at $32.08, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $56.29 indicates a 75.5% upside potential.